[ad_1]
New information comes to light about the death of a volunteer who participated in the clinical trial of the vaccine prepared by the company AstraZeneca and the University of Oxford for the coronavirus.
The man who took part in the Oxford vaccine clinical trials and died, Manolis Dermitzakis, a professor of genetics at the University of Geneva, told Sky, was in that group of volunteers who gave them the placebo.
The volunteer died in Brazil on Monday, however the news of his death was released on Wednesday afternoon without further details being known.
Brazil’s Anvisa health service said in a statement that a Covid-19 vaccine volunteer developed by AstraZeneca and the University of Oxford had died, while Brazilian media reported that the death was due to complications from the coronavirus.
However, the service did not provide official details about the death of the volunteer, citing the secrecy of the protocols.
Testing continues
According to the Brazilian authorities, the clinical trial of the vaccine will continue despite the death of the volunteer.
Oxford is not concerned about the safety of the vaccine trial and Brazilian regulators have recommended that it continue, said Stephen Rouse, the university’s director.
Meanwhile, a clinical trial of the vaccine in the US has been on hold for more than a month. Studies were stopped around the world in September when a British volunteer fell ill, but have resumed in the UK, Brazil, South Africa and India in recent weeks.
However, since pauses in vaccine studies are common, AstraZeneca and Oxford are under intense pressure to reveal more information about complications in the UK.
[ad_2]
